Skip to main content
Equibles

Notis-McConarty Edward

Position in GILD — Gilead Sciences, Inc.

CIK 1592616 BOSTON, MA
Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$644,334
-$66,453 QoQ
Shares Held
5,100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#1,266
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 90% Shared 10% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Notis-McConarty Edward holds $20,349,383 across 6 Drug Manufacturers - General names. GILD ranks #6 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JNJ
Johnson & Johnson
 30,391 $7,718,401
2 LLY
ELI LILLY & Co
 4,590 $5,505,382
3 ABBV
AbbVie Inc.
 14,837 $3,733,582
4 AMGN
Amgen Inc
 3,986 $1,443,409
5 MRK
Merck & Co., Inc.
 10,150 $1,304,275
6 GILD
Gilead Sciences, Inc.
This page 		5,100 $644,334

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $644,334 5,100
2026-03-31 $710,787 5,100
2025-12-31 $625,974 5,100
2025-09-30 $566,100 5,100
2025-06-30 $565,437 5,100
2025-03-31 $571,455 5,100
2024-12-31 $471,087 5,100
2024-09-30 $427,584 5,100
2024-06-30 $349,911 5,100
2024-03-31 $373,575 5,100
2023-12-31 $413,151 5,100
2023-09-30 $382,194 5,100
2023-06-30 $393,057 5,100
2023-03-31 $423,147 5,100
2022-12-31 $437,835 5,100
2022-09-30 $326,957 5,300
2022-06-30 $327,593 5,300
2022-03-31 $481,545 8,100
2021-12-31 $588,141 8,100
2021-09-30 $565,785 8,100
2021-06-30 $516,450 7,500
2021-03-31 $517,040 8,000
2020-12-31 $495,210 8,500
2020-09-30 $695,090 11,000
2020-06-30 $846,340 11,000
2020-03-31 $822,360 11,000

Report a Problem

Category
Description
Email (optional, for follow-up)